Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of simvastatin on aminobisphosphonate-induced Vgamma9Vdelta2 T-cell activation
NL-OMON26533Active, not recruiting
- Sponsor
- Prof. dr. H.M.W. Verheul, MD, PhD Head Department of Medical Oncology VU University Medical Center De Boelelaan 1117 1081 HV Amsterdam The Netherlands Tel: +31 (0)20-4444321/300 Fax: + 31 (0)20-4444079 Email: [email protected]
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of simvastatin in bone metastases (2 arms), sponsored by Prof. dr. H.M.W. Verheul, MD, PhD Head Department of Medical Oncology VU University Medical Center De Boelelaan 1117 1081 HV Amsterdam The Netherlands Tel: +31 (0)20-4444321/300 Fax: + 31 (0)20-4444079 Email: [email protected]. Primary endpoints: Phenotypic changes in circulating Vgamma9Vdelta2 T cells, Functional changes in circulating Vgamma9Vdelta2 T cells and 1 more. Started Sep 2010; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
bone metastases
Beyond the preview
Go deeper on NL-OMON26533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26533.